Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Is Bloom Gone From Rosy ANDA Approvals Figures?

Nov 12 2018

• By Derrick Gingery

Generics

Related Content

US FDA Sets Generic Approval Record, But Generic Sponsors Aren't Celebrating

Oct 12 2018

ANDA Submissions To US FDA Expected To Decline; Generic User Fees For FY 2019 Will Rise

Jul 29 2018

ANDA Approvals Break Record, May Set New Normal

Jul 11 2017

There's The Bolus! ANDA Sponsors Race To Avoid User Fee Spike

Oct 10 2017

Gottlieb's 2018 Generic Drug Approval Goal May Be In Doubt

May 17 2018

Lack Of Priority? No ANDAs Approved Using Expedited Pathway In FY 2018

Nov 05 2018

Democrat-Controlled House Will Turn Up The Volume On Drug Pricing

Nov 07 2018

Additional Topics

United States Generic Drugs Pricing Debate Regulation FDA BioPharmaceutical

More from Generics

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.